F. Steffen Krause

Radiochemotherapy After Transurethral Resection for High-Risk T1 Bladder Cancer: An Alternative to Intravesical Therapy or Early Cystectomy?

Carolin Wolze, Dirk G. Engehausen, Oliver J. Ott et al. · Journal of Clinical Oncology · 2006 · 111 citations · Full text

Radiochemotherapy With Cisplatin and 5-Fluorouracil After Transurethral Surgery in Patients With Bladder Cancer

Dirk G. Engehausen, F. Steffen Krause, Thomas Papadopoulos et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 97 citations

Urology, Surgical Oncology, Radiation Therapy +5

15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment.

F. Steffen Krause, Bernhard Walter, Oliver J. Ott et al. · PubMed · 2011 · 89 citations

The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer

Mario Richterstetter, Bernd Wullich, Kerstin Amann et al. · British Journal of Urology · 2012 · 82 citations

Management of Superficial Recurrences in an Irradiated Bladder After Combined-Modality Organ-Preserving Therapy

Michael Wittlinger, Dirk G. Engehausen, F. Steffen Krause et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 49 citations

Combined-modality Organ-preserving Therapy, Irradiated Bladder, Urology +8